ZANON, EZIO
 Distribuzione geografica
Continente #
AS - Asia 37
NA - Nord America 32
EU - Europa 19
Totale 88
Nazione #
US - Stati Uniti d'America 32
CN - Cina 20
SG - Singapore 16
IT - Italia 8
GB - Regno Unito 6
DE - Germania 2
FI - Finlandia 2
AM - Armenia 1
IE - Irlanda 1
Totale 88
Città #
Singapore 14
Beijing 9
Ashburn 4
Guangzhou 4
Padova 4
Santa Clara 4
Brendola 3
Dallas 2
Helsinki 2
London 2
Newcastle upon Tyne 2
Stoke-on-Trent 2
Centralia 1
Dublin 1
Falkenstein 1
Frankfurt am Main 1
Milan 1
Temecula 1
Yerevan 1
Totale 59
Nome #
Emicizumab in acquired hemophilia A: pros and cons of a new approach to the prevention and treatment of bleeding 23
A multicenter, real-world experience with recombinant FXIII for the treatment of patients with FXIII deficiency: from pharmacokinetics to clinical practice. The Italian FXIII Study 23
Albumin-Fusion Recombinant FIX in the Management of People with Hemophilia B: An Evidence-Based Review 19
Real-World Clinical Outcomes and Replacement Factor VIII Consumption in Patients with Haemophilia A in Italy: A Comparison between Prophylaxis Pre and Post Octocog Alfa (BAY 81-8973) 16
Very high risk of intracranial hemorrhage and severe outcomes in adult patients with mild hemophilia: Sub-analysis of the EMO.REC Registry 12
Totale 93
Categoria #
all - tutte 978
article - articoli 978
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.956


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223 0 0 0 0 0 0 0 0 0 0 0 3
2022/202320 1 0 0 0 5 0 0 3 2 3 6 0
2023/202442 0 4 4 5 5 3 4 3 1 7 1 5
2024/202528 0 20 5 3 0 0 0 0 0 0 0 0
Totale 93